BMS-986528

· Bristol-Myers Squibb

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for BMS-986528, covering 2026-02-23 to 2026-02-23. Get the full timeline:

Most recent: Clinical Trial Update: A Study of BMS-986528 in Participants With Refractory Rheumatoid Arthritis [Phase 1, Phase 2]